References
1. Quintana R.A., Bui L.P., Moudgil R., Palaskas N., Hassan S., Abe J.I., Mouhayar E., Yusuf S.W., Hernandez A., Banchs J. Speckle-tracking echocardiography in cardio-oncology and beyond. Tex Heart Inst J. 2020; 47 (2): 96–107. DOI: https://doi.org/10.14503/THIJ-18-6736 PMID: 32603473; PMCID: PMC 7328079.
2. Fava A.M., Meredith D., Desai M.Y. Clinical applications of echo strain imaging: a current appraisal. Curr Treat Options Cardiovasc Med. 2019; 21 (10): 50. DOI: https://doi.org/10.1007/s11936-019-0761-0 (published Online First: 2019/09/02)
3. Luis S., Chan J., Pellikka P. Echocardiographic assessment of left ventricular systolic function: an overview of contemporary techniques, including speckle-tracking echocardiography. Mayo Clin Proc. 2019; 94 (1): 125–38. DOI: https://doi.org/10.1016/j.mayocp.2018.07.017 (published Online First: 2019/01/07)
4. McGregor P., Moura F., Banchs J., et al. Role of myocardial strain imaging in surveillance and management of cancer therapeutics-related cardiac dysfunction: a systematic review. Echocardiography. DOI: https://doi.org/10.1111/echo.14944 (published Online First: 2020/12/06)
5. Kirkham A., Pituskin E., Paterson D. Does cancer affect cardiac function prior to cancer therapy exposure? Can J Cardiol. 2018; 34 (3): 234–5. DOI: https://doi.org/10.1016/j.cjca.2017.12.019 (published Online First: 2018/02/06)
6. Tadic M., Genger M., Baudisch A., et al. Left ventricular strain in chemotherapy-naive and radiotherapy-naive patients with cancer. Can J Cardiol. 2018; 34 (3): 281–7. DOI: https://doi.org/10.1016/j.cjca.2017.11.018
7. Venneri L., Khattar R. Cancer and myocardial dysfunction: is there a link? Expert Rev Cardiovasc Ther. 2016; 14 (11): 1207–9. DOI: https://doi.org/10.1080/14779072.2016.1226129 (published Online First: 2016/08/20)
8. Venneri L., Khattar R. Cancer and myocardial dysfunction: is there a link? Expert Rev Cardiovasc Ther. 2016; 14 (11): 1207–9. DOI: https://doi.org/10.1080/14779072.2016.1226129 (published Online First: 2016/08/20)
9. Akam-Venkata J., Kadiu G., Galas J., Aggarwal S. Pediatric malignancies: Is the prechemotherapy left ventricular function normal? Echocardiography. 2019; 36 (9): 1727–35. DOI: https://doi.org/10.1111/echo.14461 Epub 2019 Aug 31. PMID: 31471982.
10. McGregor P., Moura F., Banchs J. et al. Role of myocardial strain imaging in surveillance and management of cancer therapeutics-related cardiac dysfunction: a systematic review. Echocardiography. 2020; 38 (2): 314–28. DOI: https://doi.org/10.1111/echo.14944 (published Online First: 2020/12/06)
11. Cocco L., Chiaparini A., Saffi M., et al. Global longitudinal strain for the early detection of chemotherapy-induced cardiotoxicity: a systematic review and meta-analysis. Clin Oncol (R Coll Radiol). 2022; 34 (8): 514–25. DOI: https://doi.org/10.1016/j.clon.2022.05.001 (published Online First: 20220527)
12. Thavendiranathan P., Negishi T., Somerset E. et al. Strain-guided management of potentially cardiotoxic cancer therapy. J Am Coll Cardiol. 2020; 77 (4): 392–401. DOI: https://doi.org/10.1016/j.jacc.2020.11.020 (published Online First: 2020/11/22)
13. Tadic M., Baudisch A., Haßfeld S., et al. Right ventricular function and mechanics in chemotherapy- and radiotherapy-naïve cancer patients. Int J Cardiovasc Imaging. 2018; 34 (10): 1581–7. DOI: https://doi.org/10.1007/s10554-018-1379-0 Epub 2018 May 24. PMID: 29799062.
14. Fava A., Meredith D. Desai M. Clinical applications of echo strain imaging: a current appraisal. Curr Treat Options Cardiovasc Med. 2019; 21 (10): 50. DOI: https://doi.org/10.1007/s11936-019-0761-0 (published Online First: 2019/09/02)
15. Luis S., Chan J. Pellikka P. Echocardiographic assessment of left ventricular systolic function: an overview of contemporary techniques, including speckle-tracking echocardiography. Mayo Clin Proc. 2019; 94 (1): 125–38. https://doi.org/10.1016/j.mayocp.2018.07.017 (published Online First: 2019/01/07)
16. Bergamini C., Dolci G., Rossi A., Torelli F., Ghiselli L., Trevisani L., Vinco G., Truong S., La Russa F., Golia G., Molino A., Benfari G., Ribichini F.L. Left atrial volume in patients with HER 2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity. Clin Cardiol. 2018; 41(3): 349–53. DOI: https://doi.org/10.1002/clc.22872 Epub 2018 Mar 22. PMID: 29569424; PMCID: PMC 6490137.
17. Tadic M., Genger M., Cuspidi C., Belyavskiy E., et al. Phasic left atrial function in cancer patients before initiation of anti-cancer therapy. Journal of Clinical Medicine. 2019; 8 (4): 421. DOI: https://doi.org/10.3390/jcm8040421
18. Zhou Q., Shen J., Liu Y., et al. Assessment of left ventricular systolic function in patients with iron deficiency anemia by three-dimensional speckle-tracking echocardiography. Anatol J Cardiol. 2017; 18 (3): 194–9.
19. Roberts W., Bodey G., Wertlake P. The heart in acute leukemia. A study of 420 autopsy cases. Am J Cardiol. 1968; 21 (3): 388–412. DOI: https://doi.org/10.1016/0002-9149(68)90143-4 PMID: 4295426.
20. Corda A., Pinna Parpaglia M., Sotgiu G., et al. Use of 2-dimensional speckle-tracking echocardiography to assess left ventricular systolic function in dogs with systemic inflammatory response syndrome. J Vet Intern Med. 2019; 33 (2): 423–31.